PCSA icon

Processa Pharmaceuticals

18 hedge funds and large institutions have $3.22M invested in Processa Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.13M 373,598
ACM
2
AIGH Capital Management
Maryland
$915K 303,703
WVP
3
Worth Venture Partners
New Jersey
$214K 70,954
Geode Capital Management
4
Geode Capital Management
Massachusetts
$195K 64,902
VCA
5
Verdence Capital Advisors
Maryland
$180K 59,884 -3,343 -5%
Janney Montgomery Scott
6
Janney Montgomery Scott
Pennsylvania
$139K 46,231
State Street
7
State Street
Massachusetts
$125K 41,486
CBA
8
Coastal Bridge Advisors
Connecticut
$98K 32,500
BlackRock
9
BlackRock
New York
$87K 29,088 -1,413 -5%
SCM
10
Solas Capital Management
Connecticut
$69K 22,844 -173,306 -88%
Northern Trust
11
Northern Trust
Illinois
$46K 15,401
TRCT
12
Tower Research Capital (TRC)
New York
$9K 3,134 +1,521 +94%
Wells Fargo
13
Wells Fargo
California
$9K 3,139 +3,076 +4,883%
AF
14
Allworth Financial
California
$5K 1,700
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$3K 1,000
UBS Group
16
UBS Group
Switzerland
$3K 1,115 +897 +411%
EIM
17
Essex Investment Management
Massachusetts
-73,180 Closed
VRM
18
Vectors Research Management
New York
-4,000 Closed
Bank of America
19
Bank of America
North Carolina
-7 Closed
CFGS
20
Concourse Financial Group Securities
Alabama
Morgan Stanley
21
Morgan Stanley
New York
$0 1 +1 New
WT
22
Whittier Trust
California
$0 22 +22 New